Evidence map›Paper›PMID 34489524›Full record

ArticleInternational journal of obesity (2005)2022

Leptin resistance before and after obesity: evidence that tissue glucose uptake underlies adipocyte enlargement and liver steatosis/steatohepatitis in Zucker rats from early-life stages.

Maria Angela Guzzardi, Letizia Guiducci, Daniela Campani, Federica La Rosa, Andrea Cacciato Insilla, Antonietta Bartoli, Manuela Cabiati, Vincenzo De Sena, Silvia Del Ry, Silvia Burchielli and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of obesity (2005), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Effect ofAntioxidants (Basel, Switzerland) · 2024
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Maria Angela Guzzardi *Institute of Clinical Physiology, National Research Council (CNR), Pisa, Italy.ORCID http://orcid.org/0000-0001-9574-5088
Letizia Guiducci *Institute of Clinical Physiology, National Research Council (CNR), Pisa, Italy.ORCID http://orcid.org/0000-0003-3330-3238
Daniela CampaniDepartment of Surgical, Medical, Molecular Pathology and Critical Care Medicine, Division of Pathology, Pisa University Hospital, Pisa, Italy.
Federica La RosaInstitute of Clinical Physiology, National Research Council (CNR), Pisa, Italy.
Andrea Cacciato InsillaDepartment of Surgical, Medical, Molecular Pathology and Critical Care Medicine, Division of Pathology, Pisa University Hospital, Pisa, Italy.
Antonietta BartoliInstitute of Clinical Physiology, National Research Council (CNR), Pisa, Italy.ORCID http://orcid.org/0000-0002-6534-1805
Manuela CabiatiInstitute of Clinical Physiology, National Research Council (CNR), Pisa, Italy.
Vincenzo De SenaInstitute of Clinical Physiology, National Research Council (CNR), Pisa, Italy.
Silvia Del RyInstitute of Clinical Physiology, National Research Council (CNR), Pisa, Italy.ORCID http://orcid.org/0000-0001-7163-245X
Silvia BurchielliGabriele Monasterio Foundation, Pisa, Italy.ORCID http://orcid.org/0000-0002-8237-3921
Ferruccio BoninoInstitute of Biostructure and Bioimaging (IBB), National Research Council (CNR), Naples, Italy.
Patricia IozzoInstitute of Clinical Physiology, National Research Council (CNR), Pisa, Italy. patricia.iozzo@ifc.cnr.it.ORCID http://orcid.org/0000-0001-6443-7074
Istituto di Fisiologia Clinica · ITAzienda Ospedaliera Universitaria Pisana · ITFondazione Toscana Gabriele Monasterio · ITInstitute of Biostructure and Bioimaging · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLeptin resistance occurs in obese patients, but its independent contribution to adiposity and the accompanying metabolic diseases, i.e., diabetes, liver steatosis, and steatohepatitis, remains to be established. This study was conducted in an extreme model of leptin resistance to investigate mechanisms initiating diabetes, fat expansion, liver steatosis, and inflammatory disease, focusing on the involvement of glucose intolerance and organ-specific glucose uptake in brown and subcutaneous adipose tissues (BAT, SAT) and in the liver.

methodsWe studied preobese and adult Zucker rats (fa/fa, fa/+ ) during fasting or glucose loading to assess glucose tolerance. Relevant pancreatic and intestinal hormonal levels were measured by Milliplex. Imaging of

resultsPreobese fa/fa pups showed impaired glucose tolerance, adipocyte enlargement, hepatic microsteatosis, and lobular inflammation, with elevated hepatic post-glucose load glucose uptake and production. Adult fa/fa rats had more severe glucose intolerance, fasting hyperglycemia, hormonal abnormalities, elevated glucose uptake in SAT and BAT, and more markedly in the liver, together with macrosteatosis, and highly prevalent hepatic inflammation. Organ glucose uptake was proportional to the degree of fat accumulation and tissue inflammation and was able to dissect healthy from NAFLD and NAFLD/NASH livers. Most severe NASH livers showed a decline in glucose uptake and liver enzymes.

conclusionsIn fa/fa Zucker rats, leptin resistance leads to glucose intolerance, mainly due to hepatic glucose overproduction, preceding obesity, and explaining pancreatic and intestinal hormonal changes and fat accumulation in adipocytes and hepatocytes. Our data support the involvement of liver glucose uptake in the pathogenesis of liver inflammatory disease. Its potential as more generalized biomarker or diagnostic approach remains to be established outside of our leptin-receptor-deficient rat model.

Indexed as

AdipocytesAnimalsDisease Models, AnimalFatty LiverGlucoseLeptinObesityRatsRats, ZuckerGlucoseLeptin

Identifiers

PMID34489524
OpenAlexW3198598050

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.